What this test measures
Carcinoembryonic antigen (CEA) is a glycoprotein expressed normally during fetal gut development and abnormally on adult adenocarcinoma cells, particularly colorectal cancer. CEA is shed into the bloodstream and is measured in serum by immunoassay.
It is elevated in roughly 70% of colorectal cancers, particularly metastatic disease, but is also raised in cancers of the lung, breast, pancreas, stomach and ovary. Modest elevations occur in many benign conditions — smoking (most common cause of mild elevation in adults), inflammatory bowel disease, pancreatitis, diverticular disease, peptic ulcer, chronic lung disease, and cirrhosis.
Why it matters
CEA has clearly defined clinical uses:
• Pre-operative baseline before colorectal cancer surgery (prognostic; very high values suggest occult metastatic disease) • Post-operative monitoring for recurrence — typically every 3 months for the first 3 years, then 6-monthly to year 5 • Monitoring response to chemotherapy in metastatic disease
It is NOT recommended as a screening test for asymptomatic adults — NCCN and ASCO are explicit. Screening for colorectal cancer is done with FIT / FOBT and colonoscopy. CEA misses many early colorectal cancers and produces false positives from benign conditions (especially smoking), making it unsuitable for population screening.
How to prepare
No fasting required. A standard venous blood sample. Mention smoking status (current smokers commonly have mildly elevated CEA — 5–10 ng/mL — that is not cancer-related). Mention any history of colorectal cancer, recent surgery, chemotherapy, inflammatory bowel disease, pancreatitis, or chronic lung / liver disease. Stop high-dose biotin supplements 72 hours before if possible.
Markers & reference ranges
Reference ranges below are typical adult values. Your lab's reported range may differ slightly based on the assay platform and patient demographics — always read your report against the range printed on it.
| Marker | Normal range | If low | If high |
|---|---|---|---|
| CEA (ng/mL)[1][2][3] | Non-smokers: < 3 ng/mL · Smokers: up to 5 ng/mL | Low / normal CEA in a treated colorectal cancer patient is reassuring but does not exclude recurrence — about 30% of recurrences are CEA-negative. Combine with imaging and colonoscopy. | 3–10 ng/mL: nonspecific — smoking, IBD, hepatitis, diverticulitis, peptic ulcer, COPD. 10–100 ng/mL: more concerning for malignancy in the right clinical setting. > 100 ng/mL: strongly suggests advanced or metastatic cancer. |
CEA — appropriate and inappropriate uses
| Context | Use CEA? | Notes |
|---|---|---|
| Colorectal cancer screening (asymptomatic) | No | Use FIT / FOBT + colonoscopy |
| Pre-operative baseline in colorectal cancer | Yes | Prognostic, baseline for monitoring |
| Post-curative-resection surveillance | Yes | Every 3 months for 3 years, then 6-monthly to year 5 |
| Monitoring metastatic colorectal cancer | Yes | Track response to chemotherapy |
| Lung / breast / pancreatic cancer monitoring | Selective | Less specific; combine with imaging |
| Workup of solitary liver lesion | Adjunct | High CEA + colon mass — colorectal metastasis likely |
Frequently asked questions
Can CEA detect colon cancer early?
No. CEA is not recommended as a screening test for asymptomatic adults. It misses many early colorectal cancers and produces false positives in smokers and other benign conditions. Screening is best done with annual FIT / FOBT and periodic colonoscopy.
My CEA is 6 ng/mL but I smoke — is that cancer?
In a current smoker, mild CEA elevation (5–10 ng/mL) is most often a smoking effect, not cancer. Persistent elevation despite stopping smoking, or rising trend, warrants further evaluation.
When is CEA most useful?
Pre-operative baseline before colorectal cancer surgery, monitoring for recurrence after curative resection, and tracking response to chemotherapy in metastatic disease.
How often should CEA be checked after colon cancer surgery?
NCCN suggests every 3 months for the first 2–3 years (highest recurrence risk), then 6-monthly through year 5. A rising trend triggers imaging (CT abdomen / pelvis) even if absolute value is below "normal".
Do I need to fast?
No.
How long does the report take?
Most NABL labs deliver CEA results in 24 hours.
My CEA is rising slowly but my CT scan is normal — what next?
A persistent rising CEA after colorectal cancer treatment, even with normal CT, warrants further imaging — colonoscopy, PET-CT — to look for early recurrence not yet visible on routine CT.
Related Oncology / Tumor Markers tests
Tests commonly ordered alongside CARCINO EMBRYONIC ANTIGEN (CEA), or that help interpret an unexpected result.
Sources & references
- NCCN — Colon Cancer Guidelines · accessed 2026-05-30T00:00:00.000Z
- American Cancer Society — Colorectal Cancer Tests · accessed 2026-05-30T00:00:00.000Z
- NCBI StatPearls — Carcinoembryonic Antigen · accessed 2026-05-30T00:00:00.000Z
- ASCO — Tumor Markers in GI Cancer · accessed 2026-05-30T00:00:00.000Z
Book with Zelnoo
Get your CARCINO EMBRYONIC ANTIGEN (CEA) test done at home — transparent prices, NABL-accredited labs.
Zelnoo lets you compare diagnostic test prices across NABL-accredited labs in Mumbai & Thane, book a free home phlebotomist visit, and receive digital reports in 24–48 hours into a consent-first report vault. No subscriptions, no membership fees — pay only for the test you book.
Book CARCINO EMBRYONIC ANTIGEN (CEA) now